Trevena Inc (TRVN.OQ)
22 May 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|59||2013||Independent Chairman of the Board|
|59||President, Chief Executive Officer, Director|
|55||2018||Chief Operating Officer, Executive Vice President|
|47||2016||Chief Administrative Officer, Senior Vice President, General Counsel, Secretary|
|2018||Senior Vice President and Chief Medical Officer|
- BRIEF-Trevena Q1 Loss Per Share $0.14
- BRIEF-Trevena Inc And Jiangsu Nhwa Pharmaceutical Announce License Agreement For Oliceridine In China
- BRIEF-Trevena Says Chief Financial Officer Roberto Cuca Will Resign, Effective May 3, 2018
- BRIEF-Trevena Announces Retirement Of Maxine Gowen, Ph.D., Effective October 1, And Planned Promotion Of Carrie L. Bourdow To President And Chief Executive Officer
- BRIEF-Trevena Reports Q4 Loss Per Share $0.24